CSPIA
CELU icon

Cary Street Partners Investment Advisory’s Celularity CELU Stock Holding History

Cary Street Partners Investment Advisory’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-100
Closed -$222 – 810
2023
Q3 		$222 Hold
100
– – ﹤0.01% 1824
2023
Q2 		$533 Hold
100
– – ﹤0.01% 1684
2023
Q1 		$620 Hold
100
– – ﹤0.01% 1598
2022
Q4 		$1.29K Buy
+100
New +$1.84K ﹤0.01% 1560

Other funds holding CELU

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFO
Biltmore Family Office Charlotte, North Carolina $716M AUM 21.09% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
IIA
IPG Investment Advisors San Diego, California $582M AUM 33.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cary Street Partners Investment Advisory's CELU Position: Q4 2023 in Review

Cary Street Partners Investment Advisory sold out of Celularity (CELU) in Q4 2023, closing a stake of 100 shares — an estimated $222 sold.

Cary Street Partners Investment Advisory first reported a position in CELU in Q4 2022 and held it in 4 quarters. The position peaked at $1.29K in Q4 2022. 37 funds tracked by Wall St. Rank hold CELU as of Q4 2023.

  • Cary Street Partners Investment Advisory reported no remaining Celularity position as of Q4 2023 after selling out during the quarter.
  • Cary Street Partners Investment Advisory sold 100 Celularity shares in Q4 2023, an estimated $222.
  • Cary Street Partners Investment Advisory first reported a position in Celularity in Q4 2022 and held it in 4 quarters.
  • Cary Street Partners Investment Advisory's Celularity position peaked at $1.29K in Q4 2022.
  • 37 funds tracked by Wall St. Rank held Celularity as of Q4 2023.

Based on Cary Street Partners Investment Advisory's 13F filing for Q4 2023, filed 5 Feb 2024.